microdosing semaglutide vs tirzepatide for Microdosing GLP-1 Medications: Risks and

Myth: Taking it early makes it work faster False

Blamed but not at fault: Anti-obesity medication adverse effects misidentified as perioperative complications a comprehensive review and medicolegal warning for anesthesiologists

However, the FDA is giving compounders a 60- or 90-day wind-down period, depending on the type of compounding facility, to avoid unnecessary disruption to patient treatment and to help facilitate an orderly transition. The agency intends to exercise enforcement discretion (i.e., not take enforcement action) until April 22 for compounding performed by state-licensed pharmacies and physicians, and until May 22 for FDA-registered outsourcing facilities

Considering the role of enzymes like DPP-4 and NEP in the metabolism of liraglutide, how might inhibitors of these enzymes impact the drugs efficacy or duration of action

Establish a Routine : Consistency is key